What is a stock summary page? Click here for an overview.
Business Description
Optomed PLC
ISIN : FI4000410881
Share Class Description:
FRA:36U0: Ordinary SharesCompare
Compare
Traded in other countries / regions
OPTOMED.Finland36U0.GermanyOPTOMh.UK IPO Date
2022-05-16Description
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.75 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -1.7 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.9 | |||||
| Beneish M-Score | -2.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10 | |||||
| 3-Year EBITDA Growth Rate | -10.3 | |||||
| 3-Year EPS without NRI Growth Rate | -1.4 | |||||
| 3-Year FCF Growth Rate | 21.4 | |||||
| 3-Year Book Growth Rate | -1.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 37.44 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.36 | |||||
| 9-Day RSI | 42.76 | |||||
| 14-Day RSI | 41.9 | |||||
| 3-1 Month Momentum % | -10.79 | |||||
| 6-1 Month Momentum % | -7.68 | |||||
| 12-1 Month Momentum % | -6.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.81 | |||||
| Quick Ratio | 2.46 | |||||
| Cash Ratio | 1.87 | |||||
| Days Inventory | 175.12 | |||||
| Days Sales Outstanding | 67.2 | |||||
| Days Payable | 174.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 | |||||
| Shareholder Yield % | 2.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.28 | |||||
| Operating Margin % | -39.62 | |||||
| Net Margin % | -36.23 | |||||
| FCF Margin % | -28.48 | |||||
| ROE % | -24.17 | |||||
| ROA % | -17.7 | |||||
| ROIC % | -31.43 | |||||
| 3-Year ROIIC % | 265.37 | |||||
| ROC (Joel Greenblatt) % | -134.37 | |||||
| ROCE % | -18.58 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.24 | |||||
| PB Ratio | 2.96 | |||||
| Price-to-Tangible-Book | 7.33 | |||||
| EV-to-EBIT | -13.34 | |||||
| EV-to-EBITDA | -28.23 | |||||
| EV-to-Revenue | 4.2 | |||||
| EV-to-FCF | -14.76 | |||||
| Price-to-GF-Value | 1.03 | |||||
| Price-to-Net-Current-Asset-Value | 9.31 | |||||
| Price-to-Net-Cash | 28.71 | |||||
| Earnings Yield (Greenblatt) % | -7.5 | |||||
| FCF Yield % | -6.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Optomed PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 15.04 | ||
| EPS (TTM) (€) | -0.3 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 63.37 | ||
| 14-Day RSI | 41.9 | ||
| 14-Day ATR (€) | 0.098618 | ||
| 20-Day SMA (€) | 3.60175 | ||
| 12-1 Month Momentum % | -6.56 | ||
| 52-Week Range (€) | 3.205 - 7.16 | ||
| Shares Outstanding (Mil) | 19.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Optomed PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Optomed PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Optomed PLC Frequently Asked Questions
What is Optomed PLC(FRA:36U0)'s stock price today?
The current price of FRA:36U0 is €3.45. The 52 week high of FRA:36U0 is €7.16 and 52 week low is €3.21.
When is next earnings date of Optomed PLC(FRA:36U0)?
The next earnings date of Optomed PLC(FRA:36U0) is 2025-05-06.
Does Optomed PLC(FRA:36U0) pay dividends? If so, how much?
Optomed PLC(FRA:36U0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers